Results 101 to 110 of about 19,743 (212)
Salmonella meningitis a rare presentation in adult [PDF]
, 2016 Salmonella is a leading cause of food-borne infections worldwide. There are more than 2500 different serovars of salmonella enterica found to date, causing primarily gastroenteritis.
latif, Anum +2 more
core +1 more source
Muscle function in the critically ill : clinical and experimental investigations [PDF]
, 2011 It is common that critically ill patients develop muscle weakness in the intensive care unit (ICU), not only delaying mobilisation and increasing the risk of co-morbidities, but also prolonging rehabilitation after hospital care.
Ahlbeck, Karsten
core +1 more source
Journal of Clinical Pharmacy and Therapeutics, Volume 2026, Issue 1, 2026.Background High‐dose methylprednisolone pulse therapy is being increasingly used in the treatment of neurological disorders; however, there is still a lack of studies on the side effects associated with this treatment regimen in the context of neurological diseases.
Baotian Wang +7 more
wiley +1 more source
Infectio, 2023 Guillain-Barré syndrome (GBS) is an immune-mediated condition affecting both the motor and sensory spinal roots and peripheric nerves. GBS is a rare entity, with its global incidence being as low as 0.81 to 1.89 cases per 100.000 person-year. Despite its
Diana Marcela Hoyos-Llanos
doaj +1 more source
Elektro fiziološki nalazi u ranom Guillain -Barréovu sindromu [PDF]
, 2011 The aim of the study was to identify the most common electrophysiological abnormalities in early Guillain-Barré syndrome (GBS). Neurophysiological data on 51 GBS patients assessed within 12 days of symptom onset were reviewed.
Ana Sruk +4 more
core +1 more source
Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies [PDF]
, 2017 OBJECTIVE: To measure the frequency, persistence, isoform specificity, and clinical correlates of neurofascin antibodies in patients with peripheral neuropathies.
Burnor, E +8 more
core +1 more source
Clinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1405-1421, December 2025.Several regulatory initiatives have been made to clarify the acceptability and requirements of real‐world data and real‐world evidence (RWD/E) for the benefit/risk assessment of new medical products in Japan. The objectives of this review were to characterize the use of RWD/E in regulatory applications of new medical products and to describe the ...
Suguru Okami +2 more
wiley +1 more source
Changes in the severity and subtype of Guillain-Barré syndrome admitted to a specialist Neuromedical ICU over a 25 year period [PDF]
, 2017 We report a retrospective review of 110 patients with acute Guillain-Barré syndrome (GBS) admitted to a specialised intensive care unit (ICU) in a tertiary referral centre over a 25 year period, the start of which coincided with the widespread ...
Hirsch, NP +3 more
core +2 more sources
Health Science Reports, Volume 8, Issue 12, December 2025.ABSTRACT Background and Aim Guillain‐Barré syndrome (GBS) is an acute immune‐mediated neuropathy in which early diagnosis remains challenging because nerve conduction studies (NCS) may appear normal in the first few days after onset. Ultrasonography (US) has recently gained attention as a non‐invasive tool for evaluating peripheral nerve pathology ...
Gholamreza Shamsaei +3 more
wiley +1 more source
Peripheral nervous system involvement in multiple sclerosis [PDF]
, 2011 Fragestellung: Gibt es eine subklinische Beteiligung des peripheren Nervensystems bei Patienten mit Multipler Sklerose (MS) i) im Bereich der schnell leitenden Aα- und β-Fasern und/oder ii) im Bereich der langsam leitenden Aδ-Fasern?
Gartzen, Kristina
core +1 more source